Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial
Publication
, Journal Article
Dyke, CK; Becker, RC; Hasselblad, V; Bovill, EG; Kunitada, S; Robertson, TL; Hochman, JS; Kleiman, NS; Armstrong, PW; Harrington, RA
Published in: EUROPEAN HEART JOURNAL
September 1, 2001
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
September 1, 2001
Volume
22
Start / End Page
664 / +
Publisher
W B SAUNDERS CO LTD
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Dyke, C. K., Becker, R. C., Hasselblad, V., Bovill, E. G., Kunitada, S., Robertson, T. L., … Harrington, R. A. (2001). Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial. EUROPEAN HEART JOURNAL, 22, 664-+.
Dyke, C. K., R. C. Becker, V. Hasselblad, E. G. Bovill, S. Kunitada, T. L. Robertson, J. S. Hochman, N. S. Kleiman, P. W. Armstrong, and R. A. Harrington. “Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial.” EUROPEAN HEART JOURNAL 22 (September 1, 2001): 664-+.
Dyke CK, Becker RC, Hasselblad V, Bovill EG, Kunitada S, Robertson TL, et al. Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial. EUROPEAN HEART JOURNAL. 2001 Sep 1;22:664-+.
Dyke, C. K., et al. “Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial.” EUROPEAN HEART JOURNAL, vol. 22, W B SAUNDERS CO LTD, Sept. 2001, pp. 664-+.
Dyke CK, Becker RC, Hasselblad V, Bovill EG, Kunitada S, Robertson TL, Hochman JS, Kleiman NS, Armstrong PW, Harrington RA. Pharmacokinetic and pharmacodynamic responses of the novel factor Xa inhibitor DX-9065a: results from the Xa neutralization for atherosclerotic disease understanding (XaNADU) IB trial. EUROPEAN HEART JOURNAL. W B SAUNDERS CO LTD; 2001 Sep 1;22:664-+.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
September 1, 2001
Volume
22
Start / End Page
664 / +
Publisher
W B SAUNDERS CO LTD
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology